BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10441556)

  • 1. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
    Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
    Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
    Thaler S; Schnierle BS
    Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
    Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
    Schnierle BS; Stitz J; Bosch V; Nocken F; Merget-Millitzer H; Engelstädter M; Kurth R; Groner B; Cichutek K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8640-5. PubMed ID: 9238030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
    Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
    Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes.
    Lodge R; Subbramanian RA; Forget J; Lemay G; Cohen EA
    Gene Ther; 1998 May; 5(5):655-64. PubMed ID: 9797870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
    Suzuki S; Shimada T
    Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
    Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
    Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vector system for introducing foreign HIV-1 env genes and pseudotyping of MuLV particles with the recombinant HIV-1 envelope proteins for anti-HIV-1 assay.
    Lee MK; Seo JK; Kim HK; Cho JH; Poo H; Kim KL
    Antiviral Res; 2002 Feb; 53(2):99-111. PubMed ID: 11750936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
    Jiang A; Fisher H; Pomerantz RJ; Dornburg R
    Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
    Lin G; Murphy SL; Gaulton GN; Hoxie JA
    J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity.
    Nack U; Schnierle BS
    Virology; 2003 Oct; 315(1):209-16. PubMed ID: 14592772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.